Synonyms: ACX-362E | ACX362E
Compound class:
Synthetic organic
Comment: Ibezapolstat is a clinical stage bacterial DNA polymerase IIIC inhibitor that is in development as a novel therapeutic against C. difficile infection [2-3].
|
|
No information available. |
Summary of Clinical Use |
Ibezapolstat has progressed to Phase 2 clinical evaluation in patients with Clostridium Difficile infection (CDI). |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT04247542 | ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection | Phase 2 Interventional | Acurx Pharmaceuticals LLC | 1 |